Michael Wiederhorn
Stock Analyst at Oppenheimer
(4.76)
# 609
Out of 4,596 analysts
1091
Total ratings
59%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Rated: Buy | $500 → $590 | $532.25 | +10.85% | 118 | Jul 31, 2026 | |
| HUM Humana | Rated: Buy | $260 → $405 | $363.86 | +11.31% | 80 | Jul 30, 2026 | |
| ENSG The Ensign Group | Maintained: Buy | $210 | $178.16 | +17.87% | 88 | Jul 28, 2026 | |
| HCA HCA Healthcare | Maintained: Buy | $520 → $485 | $402.59 | +20.47% | 96 | Jul 27, 2026 | |
| CYH Community Health Systems | Maintained: Buy | $4 | $2.79 | +43.37% | 121 | Jul 24, 2026 | |
| UNH UnitedHealth Group | Rated: Buy | $405 → $500 | $414.40 | +20.66% | 88 | Jul 17, 2026 | |
| PACS PACS Group | Rated: Buy | $42 → $48 | $46.01 | +4.33% | 5 | May 13, 2026 | |
| PNTG The Pennant Group | Maintained: Buy | $40 | $40.32 | -0.79% | 18 | May 8, 2026 | |
| GRDN Guardian Pharmacy Services | Maintained: Buy | $43 | $39.53 | +8.78% | 7 | May 7, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $155 | $115.48 | +34.22% | 113 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $58 | $62.22 | -6.78% | 163 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.09 | - | 12 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $7 | $6.71 | +4.32% | 30 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 | $279.05 | +30.80% | 74 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $104.43 | n/a | 17 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.0003 | n/a | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $46.02 | n/a | 1 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $375.84 | n/a | 48 | Jun 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $0.000001 | n/a | 6 | Aug 19, 2014 |
Chemed
Jul 31, 2026
Rated: Buy
Price Target: $500 → $590
Current: $532.25
Upside: +10.85%
Humana
Jul 30, 2026
Rated: Buy
Price Target: $260 → $405
Current: $363.86
Upside: +11.31%
The Ensign Group
Jul 28, 2026
Maintained: Buy
Price Target: $210
Current: $178.16
Upside: +17.87%
HCA Healthcare
Jul 27, 2026
Maintained: Buy
Price Target: $520 → $485
Current: $402.59
Upside: +20.47%
Community Health Systems
Jul 24, 2026
Maintained: Buy
Price Target: $4
Current: $2.79
Upside: +43.37%
UnitedHealth Group
Jul 17, 2026
Rated: Buy
Price Target: $405 → $500
Current: $414.40
Upside: +20.66%
PACS Group
May 13, 2026
Rated: Buy
Price Target: $42 → $48
Current: $46.01
Upside: +4.33%
The Pennant Group
May 8, 2026
Maintained: Buy
Price Target: $40
Current: $40.32
Upside: -0.79%
Guardian Pharmacy Services
May 7, 2026
Maintained: Buy
Price Target: $43
Current: $39.53
Upside: +8.78%
Addus HomeCare
May 6, 2026
Rated: Buy
Price Target: $155
Current: $115.48
Upside: +34.22%
Apr 29, 2026
Rated: Buy
Price Target: $45 → $58
Current: $62.22
Upside: -6.78%
Mar 20, 2026
Maintained: Buy
Price Target: n/a
Current: $3.09
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: $12 → $7
Current: $6.71
Upside: +4.32%
Oct 31, 2025
Maintained: Buy
Price Target: $365
Current: $279.05
Upside: +30.80%
Aug 9, 2024
Maintained: Hold
Price Target: n/a
Current: $104.43
Upside: n/a
Mar 2, 2023
Maintained: Buy
Price Target: $3
Current: $0.0003
Upside: n/a
Feb 9, 2018
Reiterated: Buy
Price Target: $35
Current: $46.02
Upside: n/a
Jun 7, 2017
Rated: Hold
Price Target: n/a
Current: $375.84
Upside: n/a
Aug 19, 2014
Rated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a